Schnyder crystalline corneal dystrophy: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{SI}} | |||
{{Infobox medical condition | |||
| name = Schnyder crystalline corneal dystrophy | |||
| image = [[File:Schnyder_corneal_dystrophy_1.JPEG|left|thumb|Schnyder crystalline corneal dystrophy]] | |||
| caption = Corneal opacities in Schnyder crystalline corneal dystrophy | |||
| field = [[Ophthalmology]] | |||
| symptoms = [[Corneal opacity]], [[vision impairment]], [[photophobia]] | |||
| onset = Early childhood | |||
| duration = Lifelong | |||
| causes = Genetic mutation in the [[UBIAD1]] gene | |||
| risks = Family history | |||
| diagnosis = [[Slit lamp]] examination, [[genetic testing]] | |||
| differential = Other [[corneal dystrophies]], [[arcus senilis]] | |||
| treatment = [[Corneal transplantation]], [[phototherapeutic keratectomy]] | |||
| frequency = Rare | |||
| prognosis = Variable, can lead to significant vision impairment | |||
}} | |||
'''Schnyder crystalline corneal dystrophy''' (SCCD) is a rare, genetic eye disorder characterized by the accumulation of cholesterol and phospholipids in the cornea, leading to visual impairment. This condition is typically bilateral, affecting both eyes, and is known for its distinctive appearance of crystal deposits in the cornea. SCCD is classified under the broader category of [[corneal dystrophies]], a group of inherited eye disorders affecting the cornea, the clear, dome-shaped surface that covers the front of the eye. | '''Schnyder crystalline corneal dystrophy''' (SCCD) is a rare, genetic eye disorder characterized by the accumulation of cholesterol and phospholipids in the cornea, leading to visual impairment. This condition is typically bilateral, affecting both eyes, and is known for its distinctive appearance of crystal deposits in the cornea. SCCD is classified under the broader category of [[corneal dystrophies]], a group of inherited eye disorders affecting the cornea, the clear, dome-shaped surface that covers the front of the eye. | ||
==Etiology and Genetics== | ==Etiology and Genetics== | ||
SCCD is caused by mutations in the [[UBIAD1]] gene, which is responsible for the biosynthesis of coenzyme Q10 and the regulation of cholesterol and lipid metabolism in the cornea. The condition is inherited in an autosomal dominant manner, meaning that a mutation in just one of the two copies of the gene is sufficient to cause the disorder. Individuals with a family history of SCCD are at an increased risk of developing the condition. | SCCD is caused by mutations in the [[UBIAD1]] gene, which is responsible for the biosynthesis of coenzyme Q10 and the regulation of cholesterol and lipid metabolism in the cornea. The condition is inherited in an autosomal dominant manner, meaning that a mutation in just one of the two copies of the gene is sufficient to cause the disorder. Individuals with a family history of SCCD are at an increased risk of developing the condition. | ||
==Clinical Features== | ==Clinical Features== | ||
The hallmark of SCCD is the presence of crystalline deposits in the cornea, which can be observed as early as the first decade of life. However, the severity and progression of the disease vary among individuals. Some affected individuals may remain asymptomatic, while others may experience a range of symptoms, including: | The hallmark of SCCD is the presence of crystalline deposits in the cornea, which can be observed as early as the first decade of life. However, the severity and progression of the disease vary among individuals. Some affected individuals may remain asymptomatic, while others may experience a range of symptoms, including: | ||
* Decreased visual acuity | * Decreased visual acuity | ||
* Glare and light sensitivity | * Glare and light sensitivity | ||
* Foreign body sensation in the eye | * Foreign body sensation in the eye | ||
Over time, the accumulation of crystals can lead to corneal haze and significant visual impairment. | Over time, the accumulation of crystals can lead to corneal haze and significant visual impairment. | ||
==Diagnosis== | ==Diagnosis== | ||
Diagnosis of SCCD is primarily based on clinical examination, including a detailed eye examination and the observation of crystalline deposits in the cornea. Additional diagnostic tools may include: | Diagnosis of SCCD is primarily based on clinical examination, including a detailed eye examination and the observation of crystalline deposits in the cornea. Additional diagnostic tools may include: | ||
* [[Slit lamp]] examination | * [[Slit lamp]] examination | ||
* [[Corneal topography]] | * [[Corneal topography]] | ||
* Genetic testing to identify mutations in the UBIAD1 gene | * Genetic testing to identify mutations in the UBIAD1 gene | ||
==Treatment== | ==Treatment== | ||
There is no cure for SCCD, and treatment is aimed at managing symptoms and preventing progression of the disease. Options may include: | There is no cure for SCCD, and treatment is aimed at managing symptoms and preventing progression of the disease. Options may include: | ||
* Lubricating eye drops to alleviate discomfort | * Lubricating eye drops to alleviate discomfort | ||
* [[Corneal transplantation]] in cases of significant visual impairment | * [[Corneal transplantation]] in cases of significant visual impairment | ||
Advances in treatment, such as gene therapy, are under investigation and may offer hope for more effective management in the future. | Advances in treatment, such as gene therapy, are under investigation and may offer hope for more effective management in the future. | ||
==Prognosis== | ==Prognosis== | ||
The prognosis for individuals with SCCD varies. While the condition can lead to significant visual impairment, early detection and management can help to preserve vision and improve quality of life. | The prognosis for individuals with SCCD varies. While the condition can lead to significant visual impairment, early detection and management can help to preserve vision and improve quality of life. | ||
==See Also== | ==See Also== | ||
* [[Corneal dystrophy]] | * [[Corneal dystrophy]] | ||
* [[Genetic disorders]] | * [[Genetic disorders]] | ||
* [[Eye diseases]] | * [[Eye diseases]] | ||
[[Category:Eye diseases]] | [[Category:Eye diseases]] | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] | ||
[[Category:Rare diseases]] | [[Category:Rare diseases]] | ||
{{Medicine-stub}} | {{Medicine-stub}} | ||
Latest revision as of 22:53, 6 April 2025
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD medical weight loss NYC and sleep center NYC
| Schnyder crystalline corneal dystrophy | |
|---|---|
 | |
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Corneal opacity, vision impairment, photophobia |
| Complications | N/A |
| Onset | Early childhood |
| Duration | Lifelong |
| Types | N/A |
| Causes | Genetic mutation in the UBIAD1 gene |
| Risks | Family history |
| Diagnosis | Slit lamp examination, genetic testing |
| Differential diagnosis | Other corneal dystrophies, arcus senilis |
| Prevention | N/A |
| Treatment | Corneal transplantation, phototherapeutic keratectomy |
| Medication | N/A |
| Prognosis | Variable, can lead to significant vision impairment |
| Frequency | Rare |
| Deaths | N/A |
Schnyder crystalline corneal dystrophy (SCCD) is a rare, genetic eye disorder characterized by the accumulation of cholesterol and phospholipids in the cornea, leading to visual impairment. This condition is typically bilateral, affecting both eyes, and is known for its distinctive appearance of crystal deposits in the cornea. SCCD is classified under the broader category of corneal dystrophies, a group of inherited eye disorders affecting the cornea, the clear, dome-shaped surface that covers the front of the eye.
Etiology and Genetics[edit]
SCCD is caused by mutations in the UBIAD1 gene, which is responsible for the biosynthesis of coenzyme Q10 and the regulation of cholesterol and lipid metabolism in the cornea. The condition is inherited in an autosomal dominant manner, meaning that a mutation in just one of the two copies of the gene is sufficient to cause the disorder. Individuals with a family history of SCCD are at an increased risk of developing the condition.
Clinical Features[edit]
The hallmark of SCCD is the presence of crystalline deposits in the cornea, which can be observed as early as the first decade of life. However, the severity and progression of the disease vary among individuals. Some affected individuals may remain asymptomatic, while others may experience a range of symptoms, including:
- Decreased visual acuity
- Glare and light sensitivity
- Foreign body sensation in the eye
Over time, the accumulation of crystals can lead to corneal haze and significant visual impairment.
Diagnosis[edit]
Diagnosis of SCCD is primarily based on clinical examination, including a detailed eye examination and the observation of crystalline deposits in the cornea. Additional diagnostic tools may include:
- Slit lamp examination
- Corneal topography
- Genetic testing to identify mutations in the UBIAD1 gene
Treatment[edit]
There is no cure for SCCD, and treatment is aimed at managing symptoms and preventing progression of the disease. Options may include:
- Lubricating eye drops to alleviate discomfort
- Corneal transplantation in cases of significant visual impairment
Advances in treatment, such as gene therapy, are under investigation and may offer hope for more effective management in the future.
Prognosis[edit]
The prognosis for individuals with SCCD varies. While the condition can lead to significant visual impairment, early detection and management can help to preserve vision and improve quality of life.
See Also[edit]
